Wird geladen...
How I treat hepatitis C virus infection in patients with hematologic malignancies
Hepatitis C virus (HCV) infection is not uncommon in cancer patients. Over the past 5 years, treatment of chronic HCV infection in patients with hematologic malignancies has evolved rapidly as safe and effective direct-acting antivirals (DAAs) have become the standard-of-care treatment. Today, chron...
Gespeichert in:
| Veröffentlicht in: | Blood |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society of Hematology
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6033045/ https://ncbi.nlm.nih.gov/pubmed/27443290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-05-718643 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|